David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$410M |
| 2 |
Chevron
CVX
|
+$400M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$381M |
| 4 |
Williams Companies
WMB
|
+$300M |
| 5 |
SLB Ltd
SLB
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$358M |
| 3 |
Biogen
BIIB
|
+$306M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$298M |
| 5 |
Bausch Health
BHC
|
+$298M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 11.89% |
| 2 | Technology | 10.04% |
| 3 | Healthcare | 9.38% |
| 4 | Consumer Discretionary | 8.99% |
| 5 | Industrials | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORIT
2526
DELISTED
Oritani Financial Corp. New
ORIT
| $1.22M | ﹤0.01% |
76,156
+27,945
| +58% | +$422K |
|
|
JMG
2527
DELISTED
JOURNAL MEDIA GROUP INC COM
JMG
| $1.22M | ﹤0.01% |
+147,053
| New | +$1.28M |
|
2528
PUT
Flowserve
FLS
$10.2B
| $1.22M | ﹤0.01% |
+23,100
| New | +$1.29M |
|
2529
HealthStream
HSTM
$844M
| $1.21M | ﹤0.01% |
39,906
+29,831
| +296% | +$854K |
|
2530
Capital Southwest
CSWC
$1.61B
| $1.21M | ﹤0.01% |
66,052
+11,537
| +21% | +$208K |
|
2531
Eagle Bancorp
EGBN
$844M
| $1.21M | ﹤0.01% |
27,550
-1,705
| -6% | -$67.9K |
|
2532
Gerdau
GGB
$8.55B
| $1.21M | ﹤0.01% |
633,432
+76,724
| +14% | +$185K |
|
2533
Acuity Brands
AYI
$10.2B
| $1.21M | ﹤0.01% |
6,714
-14,791
| -69% | -$2.6M |
|
2534
Agnico Eagle Mines
AEM
$113B
| $1.2M | ﹤0.01% |
42,436
-2,364
| -5% | -$73.4K |
|
2535
NeoGenomics
NEO
$2.16B
| $1.2M | ﹤0.01% |
221,976
+121,440
| +121% | +$626K |
|
2536
CALL
AstraZeneca
AZN
$263B
| $1.2M | ﹤0.01% |
18,800
| – | – |
|
2537
DXP Enterprises
DXPE
$2.92B
| $1.2M | ﹤0.01% |
25,752
-59,066
| -70% | -$2.62M |
|
|
CATM
2538
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $1.2M | ﹤0.01% |
32,241
+17,399
| +117% | +$659K |
|
|
SIVB
2539
CALL
DELISTED
SVB Financial Group
SIVB
| $1.2M | ﹤0.01% |
+8,300
| New | +$1.12M |
|
|
AAT
2540
American Assets Trust
AAT
$1.42B
| $1.19M | ﹤0.01% |
30,452
-19,932
| -40% | -$808K |
|
|
RAD
2541
DELISTED
Rite Aid Corporation
RAD
| $1.19M | ﹤0.01% |
7,147
-117,349
| -94% | -$19.7M |
|
2542
Tetra Tech
TTEK
$9.42B
| $1.19M | ﹤0.01% |
+232,345
| New | +$1.19M |
|
2543
Korea Electric Power
KEP
$15.2B
| $1.19M | ﹤0.01% |
58,324
+37,655
| +182% | +$783K |
|
2544
Myers Industries
MYE
$1.23B
| $1.19M | ﹤0.01% |
62,483
+10,551
| +20% | +$186K |
|
|
ZU
2545
PUT
DELISTED
ZULILY INC CLASS A COMMON STOCK
ZU
| $1.19M | ﹤0.01% |
91,000
+40,000
| +78% | +$544K |
|
|
OREX
2546
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $1.19M | ﹤0.01% |
23,965
-58,291
| -71% | -$3.48M |
|
2547
PUT
Constellium
CSTM
$3.67B
| $1.18M | ﹤0.01% |
100,000
+8,500
| +9% | +$134K |
|
|
AFSI
2548
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $1.18M | ﹤0.01% |
36,122
+20,564
| +132% | +$621K |
|
|
OB
2549
DELISTED
Onebeacon Insurance Group Ltd
OB
| $1.18M | ﹤0.01% |
81,408
+24,547
| +43% | +$367K |
|
|
POZN
2550
DELISTED
POZEN INC
POZN
| $1.18M | ﹤0.01% |
114,466
-10,327
| -8% | -$85K |
|
Similar funds
David Shaw's Q2 2015 Portfolio in Review
As of Q2 2015, David Shaw held 4,083 positions worth $67.1B, up 2.8% from $65.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw's Q2 2015 filing shows 504 new, 1,541 increased, 1,229 reduced and 364 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $479M.
By sector, the portfolio is most concentrated in Energy at 12% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.
- David Shaw's largest Q2 2015 buy was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M.
- David Shaw added most to Gilead Sciences in Q2 2015, an estimated $410M increase.
- David Shaw's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $479M.
- David Shaw fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q2 2015, selling an estimated $164M.
- David Shaw's ten largest holdings make up 11% of its $67.1B portfolio in Q2 2015.
- David Shaw opened 504 new positions and closed 364 in Q2 2015.
- David Shaw's portfolio value rose 2.8% quarter-over-quarter to $67.1B.
Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.